Established in 1999, IMPAX Laboratories is a technology-based specialty pharmaceutical company utilizing controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the company s focus is on selected controlled-release generic versions of brand name pharmaceuticals. In the brand name pharmaceuticals market, IMPAX is developing products for the treatment of central nervous system disorders. The company s initial brand name product portfolio consists of development stage projects to which it is applying formulation and development expertise to develop differentiated, modified or controlled-release versions of marketed drug substances. The company s headquarters a housed in four facilities totalling nearly 165,000 square feet, which also serve as the development and manufacturing center for the organization. Another 113,000-square-foot facility, located in Philadelphia, serves as the company s primary commercial center, with sales, marketing, packaging and distribution. IMPAX Laboratories is headquartered in Hayward, Calif.